BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 15239599)

  • 1. [Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis].
    Ordóñez LE; Angulo ES
    Biomedica; 2004 Mar; 24(1):33-41. PubMed ID: 15239599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
    Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, treatment and risk factors of Strongyloides stercoralis in schoolchildren in Cambodia.
    Khieu V; Schär F; Marti H; Sayasone S; Duong S; Muth S; Odermatt P
    PLoS Negl Trop Dis; 2013; 7(2):e2035. PubMed ID: 23409200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An overview of Strongyloides stercoralis and its infections].
    Ardiç N
    Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
    Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
    Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
    Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
    Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
    Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strongyloides stercoralis infection in an HIV positive patient--a case report from RIMS, Imphal, Manipur.
    Pukhrambam PD; Rebachandra H; Singh NB; Singh TN
    J Commun Dis; 2010 Sep; 42(3):231-4. PubMed ID: 22471190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Strongyloides stercoralis: a puzzling parasite.
    Luvira V; Watthanakulpanich D; Pittisuttithum P
    Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloides stercoralis infection in an intestinal transplant recipient.
    Hsu CN; Tseng SH; Chang SW; Chen Y
    Transpl Infect Dis; 2013 Aug; 15(4):E139-43. PubMed ID: 23789974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infections in dogs.
    Mansfield LS; Schad GA
    J Am Vet Med Assoc; 1992 Sep; 201(5):726-30. PubMed ID: 1399774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ivermectin against Strongyloides stercoralis infection in jirds (Meriones unguiculatus).
    Sithithaworn P; Fujimaki Y; Mitsui Y; Prasanthong R; Yutanawiboonchai W; Aoki Y
    Exp Parasitol; 1998 Jun; 89(2):205-12. PubMed ID: 9635444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
    Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
    Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination: the fatal risk for a missed diagnosis of Strongyloides stercoralis infection.
    Boscolo M; Bisoffi Z
    J Infect; 2007 Sep; 55(3):284-5. PubMed ID: 17368549
    [No Abstract]   [Full Text] [Related]  

  • 17. Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin.
    Orem J; Mayanja B; Okongo M; Morgan D
    Clin Infect Dis; 2003 Jul; 37(1):152-3. PubMed ID: 12830426
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
    Benvenuti F; Carrascosa JM; Boada A; Ferrandiz C
    Eur J Dermatol; 2009; 19(4):404-5. PubMed ID: 19467975
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe strongyloidiasis in corticosteroid-treated patients.
    Fardet L; Généreau T; Cabane J; Kettaneh A
    Clin Microbiol Infect; 2006 Oct; 12(10):945-7. PubMed ID: 16961629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients].
    Corti M; Villafañe MF; Trione N; Risso D; Abuín JC; Palmieri O
    Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.